Description: Starting with a review of recent VA and FIA industry policyholder behavior experience, this session will explore several critical elements in developing a sustainable and coherent framework to translate this complex experience data to assumption models, particularly for guarantee features such as GLWBs. The discussion will include the use of industry- and company-level data in building customized predictive models, and integrating models across behaviors such as income utilization and surrenders.

Description: Reinsurance has been available for VA Guarantees for over 20 years. During that time, the reinsurance market for VA Guarantees has undergone frequent and sometimes violent transformations. Where does the market stand today? What forms and structures of reinsurance are available? Which VA Guarantee designs and features are easier to reinsure? Is reinsurance offered on both newly issued policies as well as in force/legacy books, and which vintages are difficult to reinsure? In an age of sophisticated hedging programs, what role does a reinsurer play in helping a VA writer manage this highly volatile risk? In this session, we will hear from a reinsurer that is actively writing new VA Guarantee reinsurance treaties in the U.S. and around the world, and from a VA writer that has successfully partnered with a reinsurer to enhance its VA product offering.

Description: This article discusses how small insurance companies can get into the complex equity indexed market by using alliances wherein there is one primary company and one or more secondary companies. The primary company would perform all of the functions for itself and some of the functions for the secondary companies. The companies pool assets to reach critical mass.

Description: Article explores why many integrated delivery systems are struggling and what actions they need to take to succeed.

Description: This article is a brief overview of what digital health is, how it is regulated, and who some of the big unicorns are.

Description: Whole life insurance nonforfeiture options may be actuarially equivalent at the time premium payments end. When the entire remaining lifetime of the policy is fully considered; however, significant differences emerge in expenses between paying the cash surrender value, converting to reduced paid-up, or converting to extended term insurance. This article explores how a company might manage its existing nonforfeiture options and consider what to continue to offer after a product refiling with that entire lifetime in mind.

Description: Bell is comparing his roles from that of an actuary in the USA to that of an actuary working in Cameroon, for a pan-African insurance company.

Description: Explore the value and cost of prescription drugs, how they should be defined and measured and the effects various stakeholders in the pharmacy ecosystem can have on these factors in the latest webcast. You'll investigate the impact of coverage, formulary and rebate negotiations and related benefit design. Find out how actuaries can answer questions related to the prescription drug industry, in addition to improving the access, quality and affordability of prescription drugs in the United States. Join us for this webcast and come learn about value-based contract design, negotiations, implementation and administration for prescription drugs.

Description: The Supplemental Health, DI & LTC Conference provides a unique opportunity to consider a cross-functional view of supplemental health products, individual disability insurance, and long-term care standalone and combination products.

Description: Join the PAI-SOA Joint Seminar to connect with actuaries, insurance, finance, and investment professionals from Indonesia, the Asia-Pacific region, and beyond. Enhance your professional knowledge and connections in this collaborative environment.